MedPath
FDA Approval

Irinotecan hydrochloide

March 3, 2022

Human Prescription Drug Label

Irinotecan(20 mg in 1 mL)

Manufacturing Establishments (1)

Gland Pharma Limited

Gland Pharma Limited

650540227

Products (2)

Irinotecan hydrochloride

68083-382

ANDA212993

ANDA (C73584)

INTRAVENOUS

March 3, 2022

HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
Code: 042LAQ1IISClass: ACTIBQuantity: 20 mg in 1 mL
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT

Irinotecan hydrochloide

68083-381

ANDA212993

ANDA (C73584)

INTRAVENOUS

March 3, 2022

Code: 042LAQ1IISClass: ACTIBQuantity: 20 mg in 1 mL
SODIUM HYDROXIDEInactive
Code: 55X04QC32IClass: IACT
LACTIC ACIDInactive
Code: 33X04XA5ATClass: IACT
HYDROCHLORIC ACIDInactive
Code: QTT17582CBClass: IACT
SORBITOLInactive
Code: 506T60A25RClass: IACT
© Copyright 2025. All Rights Reserved by MedPath